Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8446862 | European Journal of Cancer | 2012 | 4 Pages |
Abstract
The observations show that quantitative monitoring of mutant BCR/ABL1 subclones by LD-PCR is a powerful tool for detection of clonal evolution, subclone-expansion and subclone-depletion and can contribute to optimised management of patients with CML.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
S. Preuner, G. Mitterbauer, C. Mannhalter, S. Herndlhofer, W.R. Sperr, P. Valent, T. Lion,